Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 1998, p. 4862-4869, Vol. 64, No. 12
Institut für Industrielle
Genetik1 and
Institut für
Zellbiologie und Immunologie,
Received 24 July 1998/Accepted 7 October 1998
Recently it has been demonstrated that L-form cells of
Proteus mirabilis (L VI), which lack a periplasmic
compartment, can be efficiently used in the production and
secretion of heterologous proteins. In search of novel expression
systems for recombinant antibodies, we compared levels of single-chain
variable-fragment (scFv) production in Escherichia coli
JM109 and P. mirabilis L VI, which express four distinct
scFvs of potential clinical interest that show differences
in levels of expression and in their tendencies to form aggregates upon
periplasmic expression. Production of all analyzed scFvs in E. coli was limited by the severe toxic effect of the heterologous
product as indicated by inhibition of culture growth and the formation
of insoluble aggregates in the periplasmic space, limiting the yield of
active product. In contrast, the L-form cells exhibited nearly
unlimited growth under the tested production conditions for all
scFvs examined. Moreover, expression experiments with P. mirabilis L VI led to scFv concentrations in the range of 40 to
200 mg per liter of culture medium (corresponding to volume yields 33- to 160-fold higher than those with E. coli JM109),
depending on the expressed antibody. In a translocation inhibition
experiment the secretion of the scFv constructs was shown to be an
active transport coupled to the signal cleavage. We suppose that this
direct release of the newly synthesized product into a large volume of
the growth medium favors folding into the native active structure. The
limited aggregation of scFv observed in the P. mirabilis L
VI supernatant (occurring in a first-order-kinetics manner) was found
to be due to intrinsic features of the scFv and not related to the
expression process of the host cells. The P. mirabilis L VI
supernatant was found to be advantageous for scFv purification. A
two-step chromatography procedure led to homogeneous scFv with high
antigen binding activity as revealed from binding experiments with
eukaryotic cells.
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Procaryotic Expression of Single-Chain Variable-Fragment (scFv)
Antibodies: Secretion in L-Form Cells of Proteus
mirabilis Leads to Active Product and Overcomes the
Limitations of Periplasmic Expression in Escherichia
coli
*
Corresponding author. Mailing address: Institut
für Zellbiologie und Immunologie, Universität Stuttgart,
Allmandring 31, D-70569 Stuttgart, Germany. Phone: 049 711 685 6992. Fax: 049 711 685 7484. E-mail:
dieter.moosmayer{at}po.uni-stuttgart.de.
Applied and Environmental Microbiology, December 1998, p. 4862-4869, Vol. 64, No. 12
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|